https://orcid.org/0000-0002-6204-993X
References
- Hamada K, Oishi K, Chikumoto A, Murakawa K, Ohteru Y, Matsuda K, Sho U, Suetake R, Ohata S, Murata Y, et al. Impact of sinus surgery on type 2 airway and systemic inflammation in asthma. J Asthma. 2020;1–9. doi:10.1080/02770903.2020.1729380.
- Brusselle GG, Maes T, Bracke KR. Eosinophils in the spotlight: eosinophilic airway inflammation in nonallergic asthma. Nat Med. 2013;19(8):977–979. doi:10.1038/nm.3300.
- Yii ACA, Tay T, Choo XN, Koh MSY, Tee AKH, Wang D. Precision medicine in united airways disease: a “treatable traits” approach. Allergy. 2018;73(10):1964–1978. doi:10.1111/all.13496.
- Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM, van der Merwe R. Tezepelumab in adults with uncontrolled asthma. N Engl J Med. 2017;377(10):936–946. doi:10.1056/NEJMoa1704064.
- Bårnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respir Care. 2015;60(3):455–468. doi:10.4187/respcare.03200.
- Oka A, Matsunaga K, Kamei T, Sakamoto Y, Hirano T, Hayata A, Akamatsu K, Kikuchi T, Hiramatsu M, Ichikawa T, et al. Ongoing allergic rhinitis impairs asthma control by enhancing the lower airway inflammation. J Allergy Clin Immunol Pract. 2014;2(2):172–178. doi:10.1016/j.jaip.2013.09.018.